| 000 | 01426 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517101133.0 | ||
| 264 | 0 | _c20160712 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1550-7033 | ||
| 024 | 7 |
_a10.1166/jbn.2016.2194 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHayward, Stephen L | |
| 245 | 0 | 0 |
_aTargeted Delivery of MicroRNA125a-5p by Engineered Lipid Nanoparticles for the Treatment of HER2 Positive Metastatic Breast Cancer. _h[electronic resource] |
| 260 |
_bJournal of biomedical nanotechnology _cMar 2016 |
||
| 300 |
_a554-68 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aGene Targeting _xmethods |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipids _xchemistry |
| 650 | 0 | 4 |
_aMicroRNAs _xadministration & dosage |
| 650 | 0 | 4 |
_aNanocapsules _xchemistry |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
| 650 | 0 | 4 |
_aTransfection _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFrancis, David M | |
| 700 | 1 | _aKholmatov, Parviz | |
| 700 | 1 | _aKidambi, Srivatsan | |
| 773 | 0 |
_tJournal of biomedical nanotechnology _gvol. 12 _gno. 3 _gp. 554-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1166/jbn.2016.2194 _zAvailable from publisher's website |
| 999 |
_c26106897 _d26106897 |
||